News of the Year 2012
By Pete Shanks,
Biopolitical Times
| 12. 20. 2012
This was quite a year for reproductive and genetic technologies, and many of the biggest stories will certainly have sequels. Among the most significant topics were:
- Artificial gametes and cloning
- Inheritable genetic modification
- Prenatal, newborn and other genetic testing
- The fertility industry
- Commercial surrogacy
- Egg “donation” / egg freezing
- Eugenics as policy
- Forensic DNA / DNA databases
- Stem cells: therapies and scandals
- Synthetic biology and the bioeconomy
Artificial gametes and cloning
The Nobel Prize in Physiology or Medicine went to John Gurdon and Shinya Yamanaka, for cloning a frog and discovering how to reprogram adult cells into induced pluripotent stem (iPS) cells, respectively. Scientists are still expanding on these breakthroughs.
Mitinori Saitou and colleagues in Kyoto created mice by using sperm and eggs grown from iPS cells, though supplied ovaries were also needed, at least for the time being. This sparked immediate speculation about human applications, as did an earlier Chinese technique of generating sperm. In Korea, there was a push to remove restrictions on human research cloning, and eventually reproductive cloning. Korean animal cloning also garnered...
Related Articles
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...
By Jessica Hamzelou, MIT Technology Review | 11.07.2025
This week, we heard that Tom Brady had his dog cloned. The former quarterback revealed that his Junie is actually a clone of Lua, a pit bull mix that died in 2023.
Brady’s announcement follows those of celebrities like Paris...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...